Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.88 -0.01 (-0.15%)
At close: Nov 11, 2026 · 4:00 PM EST

Cartesian Therapeutics (RNAC) Notes Payables (2023)

Updated

Analysis

Cartesian Therapeutics (RNAC) Notes Payables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cartesian Therapeutics 210.06 Mn -304.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 12.66 Mn
Jun 30, 2023 12.66 Mn
API Access

Cartesian Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=RNAC&period=max&api_key=YOUR_API_KEY